Compounds > aluminum sulfate
Page last updated: 2024-08-22

aluminum sulfate and Infections, Pneumococcal

aluminum sulfate has been researched along with Infections, Pneumococcal in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's2 (50.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ho, PL; Lima, FA; Miyaji, EN; Oliveira, ML; Quintilio, W; Raw, I1
Cook, J; Hayakawa, Y; Hyodo, M; Karaolis, DK; Kirby, AC; McCullers, JA; Ogunniyi, AD; Paton, JC1
Anderson, PW; Forte, S; Lu, YJ; Malley, R; Thompson, CM1
Alexander, JE; Andrew, PW; Hansman, D; Lock, RA; Mitchell, TJ; Paton, JC; Peeters, CC; Poolman, JT1

Other Studies

4 other study(ies) available for aluminum sulfate and Infections, Pneumococcal

ArticleYear
Pneumococcal Surface Protein A does not affect the immune responses to a combined diphtheria tetanus and pertussis vaccine in mice.
    Vaccine, 2013, May-07, Volume: 31, Issue:20

    Topics: Alum Compounds; Animals; Antibodies, Bacterial; Bacterial Proteins; Bordetella pertussis; Chlorocebus aethiops; Diphtheria Toxin; Diphtheria-Tetanus-Pertussis Vaccine; Female; Immunity, Mucosal; Immunoglobulin G; Injections, Subcutaneous; Lipopolysaccharides; Mice; Mice, Inbred BALB C; Pertussis Toxin; Pneumococcal Infections; Pneumococcal Vaccines; Respiratory Mucosa; Streptococcus pneumoniae; Tetanus Toxin; Vaccination; Vero Cells

2013
c-di-GMP is an effective immunomodulator and vaccine adjuvant against pneumococcal infection.
    Vaccine, 2008, Aug-26, Volume: 26, Issue:36

    Topics: Adjuvants, Immunologic; Administration, Intranasal; Alum Compounds; Animals; Antibodies, Bacterial; Bacterial Proteins; Blood; Colony Count, Microbial; Cyclic GMP; Female; Immunologic Factors; Injections, Intraperitoneal; Lung; Lymph Nodes; Male; Mice; Mice, Inbred BALB C; Pneumococcal Infections; Pneumococcal Vaccines; Streptococcus pneumoniae; Streptolysins; Survival Analysis

2008
Protection against Pneumococcal colonization and fatal pneumonia by a trivalent conjugate of a fusion protein with the cell wall polysaccharide.
    Infection and immunity, 2009, Volume: 77, Issue:5

    Topics: Adhesins, Bacterial; Adjuvants, Immunologic; Administration, Intranasal; Alum Compounds; Animals; Antibodies, Bacterial; Bacterial Proteins; Cell Wall; Cholera Toxin; Injections, Subcutaneous; Interleukin-17; Lipoproteins; Mice; Mice, Inbred C57BL; Pneumococcal Infections; Pneumococcal Vaccines; Pneumonia, Pneumococcal; Polysaccharides, Bacterial; Recombinant Fusion Proteins; Streptococcus pneumoniae; Streptolysins; Vaccines, Conjugate

2009
Immunization of mice with pneumolysin toxoid confers a significant degree of protection against at least nine serotypes of Streptococcus pneumoniae.
    Infection and immunity, 1994, Volume: 62, Issue:12

    Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Antibodies, Bacterial; Bacterial Capsules; Bacterial Proteins; Bacterial Vaccines; Female; Hemolysis; Injections, Intraperitoneal; Male; Mice; Pneumococcal Infections; Serotyping; Species Specificity; Streptococcus pneumoniae; Streptolysins; Toxoids; Vaccination; Vaccines, Synthetic

1994